Development and validation of an HPLC-UV method for accelerated stability study and pharmacokinetic analysis of venlafaxine

Development and validation of an HPLC-UV method for accelerated stability study and pharmacokinetic analysis of venlafaxine

A reverse phase high performance liquid chromatography method has been developed and validated for accelerated stability study and determination of pharmacokinetic parameters of venlafaxine HCl. The chromatographic separation was carried out using ODS analytical column (250 × 4.6 mm i.d., 5 µm parti...

Full description

Bibliographic Details
Main Authors:	Muhammad Sher, Maria Ahmad, Faiza Hassan, Muhammad Naeem-ul-Hassan, Muhammad Ajaz Hussain
Format:	Article
Language:	English
Published:	Universidade de São Paulo 2020-03-01
Series:	Brazilian Journal of Pharmaceutical Sciences
Subjects:	Venlafaxine HPLC Stability Pharmacokinetics Chromatography
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502020000100514&tlng=en

Similar Items

Joint population pharmacokinetic modeling of venlafaxine and O-desmethyl venlafaxine in healthy volunteers and patients to evaluate the impact of morbidity and concomitant medication
by: Zhanzhang Wang, et al.
Published: (2022-12-01)

Venlafaxine Intoxication and Serotonin Syndrome
by: Mehmet Fatih Yörük, et al.
Published: (2018-10-01)

Venlafaxine-induced prostatism: a case report
by: Ibrahim Gundogmus, et al.
Published: (2017-04-01)

Is There a Potential of Misuse for Venlafaxine and Bupropion?
by: Fabrizio Schifano, et al.
Published: (2018-03-01)

The Effect of Venlafaxine and Topiramate in Reducing Migraine Headaches in Patients with Abnormal Electroencephalogram
by: Fariborz Khorvash, et al.
Published: (2015-05-01)

Rapid, Precise and Affordable Estimation of Venlafaxine and Its Metabolites in Highly Polluted Effluent Waters: Proof-of-Concept for Methodology
by: Snawar Hussain, et al.
Published: (2020-10-01)

Comparative Analysis between Controlled Release Paroxetine and Extended-Release Venlafaxine for Treatment of Depression
by: Vijay Kaul, et al.
Published: (2022-06-01)

Persistant genital arousal disorder and venlafaxine: A case report
by: M. Marguilho, et al.
Published: (2021-04-01)

Facial Flushing Associated with Anxiety and Improved by Venlafaxine: A Case Report
by: Qiu Y, et al.
Published: (2022-09-01)

The anti-inflammatory effects of venlafaxine in the rat model of carrageenan-induced paw edema
by: Valiollah Hajhashemi, et al.
Published: (2015-07-01)

Venlafaxine‐induced interstitial lung disease with COVID‐19 pandemic‐related depression
by: Akihito Okazaki, et al.
Published: (2022-06-01)

Postnatal development of rats exposed to fluoxetine or venlafaxine during the third week of pregnancy
by: V.A. da-Silva, et al.
Published: (1999-01-01)

A Case of Ruminative Hypomania Induced by High Dose Venlafaxine
by: E. Yıldızhan, et al.
Published: (2022-06-01)

Proconvulsant effects of high doses of venlafaxine in pentylenetetrazole-convulsive rats
by: J.G. Santos Junior, et al.
Published: (2002-04-01)

A rare case with suicide due to akathisia after use of single dose venlafaxine
by: Nermin Gündüz, et al.
Published: (2018-06-01)

Neuroleptic Malignant Syndrome After the Use of Venlafaxine in a Patient with Generalized Anxiety Disorder
by: Tsung-Chien Lu, et al.
Published: (2006-01-01)

Lithium and venlafaxine poisoning — a case report
by: Sinkovič Andreja, et al.
Published: (2013-10-01)

Comparison of efficacy and tolerability of escitalopram and venlafaxine in treatment-naïve patients with unipolar nonpsychotic depression: Is there a need to revisit the prescription patterns?
by: Harneet Kaur, et al.
Published: (2019-01-01)

Venlafaxine-induced REM sleep behavioral disorder presenting as two fractures
by: R. Ryan Williams, et al.
Published: (2017-10-01)

Development and validation of stability indicating method for the quantitative determination of venlafaxine hydrochloride in extended release formulation using high performance liquid chromatography
by: Jaspreet Kaur, et al.
Published: (2010-01-01)

Time course of effects of venlafaxine on migraine and generalized pruritus in a patient with depression
by: Yu Miyahara, et al.
Published: (2021-11-01)

Development and Validation of an HPLC-UV Detection Assay for the Determination of Clonidine in Mouse Plasma and Its Application to a Pharmacokinetic Study
by: Haitham AlRabiah, et al.
Published: (2020-09-01)

Bioanalytical Method Validation of Metformin Hydrochloride in Human Plasma by HPLC-UV for Preliminary Population-Based Pharmacokinetic Modeling Study
by: Dimas Adhi Pradana, et al.
Published: (2023-08-01)

Venlafaxine-induced Thyroiditis: A Case Report
by: Ideh Ghafour, et al.
Published: (2018-09-01)

Venlafaxine-induced spontaneous ejaculation: Case report and literature review
by: I. Gundogmus, et al.
Published: (2022-06-01)

Recent Advances in the Electrochemical Sensing of Venlafaxine: An Antidepressant Drug and Environmental Contaminant
by: Somayeh Tajik, et al.
Published: (2020-06-01)

Clinical study on the treatment of depression with venlafaxine under the guidance of pharmacogenomics testing
by: Xu Jinbing, et al.
Published: (2021-06-01)

Effects of in vitro Amitriptyline, Fluoxetine, Tranylcypromine and Venlafaxine on Saphenous Vein Grafts
by: Melek Akinci, et al.

Painful ejaculation induced by venlafaxine: a case report
by: F. Kulacaoglu
Published: (2022-06-01)

Optimization of Nasal Liposome Formulation of Venlafaxine Hydrochloride using a Box-Behnken Experimental Design
by: Sulekha Khute, MPharm, et al.
Published: (2023-01-01)

A Novel Electrochemical Sensing Platform for the Detection of the Antidepressant Drug, Venlafaxine, in Water and Biological Specimens
by: Sundas Sultan, et al.
Published: (2022-10-01)

Effect Of Chinese Herb Danzhi Xiaoyao Pills On Pharmacokinetics Of Venlafaxine In Beagles
by: Zhu Y, et al.
Published: (2019-09-01)

Preventive Effect of Central Administration of Venlafaxine on Morphine Physical Dependence, Nociception, and Blood Cortisol Level in Rat
by: Majid Motaghinejad, et al.
Published: (2014-01-01)

Acute urinary retention after venlafaxine use
by: Şaban Oğuz Demirdöğen, et al.
Published: (2017-06-01)

Study of influence of Catha edulis (Khat) chewing on oral pharmacokinetics of irbesartan in rats using a newly developed HPLC-UV method
by: Hassan A. Alhazmi, et al.
Published: (2022-03-01)

Apathy symptoms induced by low‐dose venlafaxine: Two cases
by: Shinji Sato, et al.
Published: (2020-06-01)

Chitosan Spray-Dried Microparticles for Controlled Delivery of Venlafaxine Hydrochloride
by: Inmaculada Aranaz, et al.
Published: (2017-11-01)

Optimization and evaluation of venlafaxine hydrochloride fast dissolving oral films
by: Arwa Ibrahim Al-Mogherah, et al.
Published: (2020-11-01)

Reduction of methylphenidate induced anxiety, depression and cognition impairment by various doses of venlafaxine in rat
by: Majid Motaghinejad, et al.
Published: (2015-01-01)

Administration of venlafaxine after chronic methadone detoxification blocks post-depression relapse in rats
by: Meysam Fadaei-Kenarsary, et al.
Published: (2017-08-01)